370 related articles for article (PubMed ID: 17118731)
21. Mode-of-action analysis for induction of rat liver tumors by pyrethrins: relevance to human cancer risk.
Osimitz TG; Lake BG
Crit Rev Toxicol; 2009; 39(6):501-11. PubMed ID: 19463055
[TBL] [Abstract][Full Text] [Related]
22. Dose response for formaldehyde-induced cytotoxicity in the human respiratory tract.
Conolly RB; Kimbell JS; Janszen DB; Miller FJ
Regul Toxicol Pharmacol; 2002 Feb; 35(1):32-43. PubMed ID: 11846634
[TBL] [Abstract][Full Text] [Related]
23. The genotoxic potential of glutaraldehyde in mammalian cells in vitro in comparison with formaldehyde.
Speit G; Neuss S; Schütz P; Fröhler-Keller M; Schmid O
Mutat Res; 2008 Jan; 649(1-2):146-54. PubMed ID: 18006368
[TBL] [Abstract][Full Text] [Related]
24. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
25. Development of a quantitative model incorporating key events in a hepatotoxic mode of action to predict tumor incidence.
Luke NS; Sams R; DeVito MJ; Conolly RB; El-Masri HA
Toxicol Sci; 2010 May; 115(1):253-66. PubMed ID: 20106946
[TBL] [Abstract][Full Text] [Related]
26. Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens.
Bercu JP; Jolly RA; Flagella KM; Baker TK; Romero P; Stevens JL
Regul Toxicol Pharmacol; 2010 Dec; 58(3):369-81. PubMed ID: 20801182
[TBL] [Abstract][Full Text] [Related]
27. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
28. 4-Aminobiphenyl and DNA reactivity: case study within the context of the 2006 IPCS Human Relevance Framework for Analysis of a cancer mode of action for humans.
Cohen SM; Boobis AR; Meek ME; Preston RJ; McGregor DB
Crit Rev Toxicol; 2006; 36(10):803-19. PubMed ID: 17118730
[TBL] [Abstract][Full Text] [Related]
29. Risk assessment of formaldehyde for the general population in Japan.
Naya M; Nakanishi J
Regul Toxicol Pharmacol; 2005 Dec; 43(3):232-48. PubMed ID: 16185798
[TBL] [Abstract][Full Text] [Related]
30. A mechanistic interpretation of the oncogenicity of chlorothalonil in rodents and an assessment of human relevance.
Wilkinson CF; Killeen JC
Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 1):69-84. PubMed ID: 8921547
[TBL] [Abstract][Full Text] [Related]
31. An updated mode of action and human relevance framework evaluation for Formaldehyde-Related nasal tumors.
Thompson CM; Gentry R; Fitch S; Lu K; Clewell HJ
Crit Rev Toxicol; 2020 Nov; 50(10):919-952. PubMed ID: 33599198
[TBL] [Abstract][Full Text] [Related]
32. Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action.
Cruzan G; Bus J; Banton M; Gingell R; Carlson G
Regul Toxicol Pharmacol; 2009 Nov; 55(2):205-18. PubMed ID: 19589367
[TBL] [Abstract][Full Text] [Related]
33. Critical evaluation of the cancer risk of dibromochloropropane (DBCP).
Clark HA; Snedeker SM
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2005; 23(2):215-60. PubMed ID: 16291528
[TBL] [Abstract][Full Text] [Related]
34. Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods.
Waters MD; Jackson M; Lea I
Mutat Res; 2010 Dec; 705(3):184-200. PubMed ID: 20399889
[TBL] [Abstract][Full Text] [Related]
35. Pathology and cell proliferation induced by intra-nasal instillation of aldehydes in the rat: comparison of glutaraldehyde and formaldehyde.
St Clair MB; Gross EA; Morgan KT
Toxicol Pathol; 1990; 18(3):353-61. PubMed ID: 2125143
[TBL] [Abstract][Full Text] [Related]
36. Hemangiosarcoma in rodents: mode-of-action evaluation and human relevance.
Cohen SM; Storer RD; Criswell KA; Doerrer NG; Dellarco VL; Pegg DG; Wojcinski ZW; Malarkey DE; Jacobs AC; Klaunig JE; Swenberg JA; Cook JC
Toxicol Sci; 2009 Sep; 111(1):4-18. PubMed ID: 19525443
[TBL] [Abstract][Full Text] [Related]
37. Thiazopyr and thyroid disruption: case study within the context of the 2006 IPCS Human Relevance Framework for analysis of a cancer mode of action.
Dellarco VL; McGregor D; Berry SC; Cohen SM; Boobis AR
Crit Rev Toxicol; 2006; 36(10):793-801. PubMed ID: 17118729
[TBL] [Abstract][Full Text] [Related]
38. Genetic toxicity and carcinogenicity studies of glutaraldehyde--a review.
Zeiger E; Gollapudi B; Spencer P
Mutat Res; 2005 Mar; 589(2):136-51. PubMed ID: 15795166
[TBL] [Abstract][Full Text] [Related]
39. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
40. IPCS framework for analyzing the relevance of a noncancer mode of action for humans.
Boobis AR; Doe JE; Heinrich-Hirsch B; Meek ME; Munn S; Ruchirawat M; Schlatter J; Seed J; Vickers C
Crit Rev Toxicol; 2008; 38(2):87-96. PubMed ID: 18259981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
